Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Net Cash Flow (2021 - 2026)

Valneva SE (VALN) posted Net Cash Flow of -$5.5 million for Q1 2026, up 86.87% sequentially from -$42.1 million in Q4 2025, and up 63.16% YoY from -$3.4 million in Q1 2025.

Analysis

Valneva SE (VALN) Net Cash Flow (2021 - 2026) Analysis & Trends

Valneva SE has reported Net Cash Flow for 6 years, with the latest figure at -$5.5 million in Q1 2026.

  • Quarterly Net Cash Flow rose 63.16% year-over-year to -$5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$53.6 million (down 107.07% YoY) and the FY2025 annual result came in at -$64.3 million, down 247.08% from the prior year.
  • Net Cash Flow climbed to -$5.5 million in Q1 2026 per VALN's latest filing, from -$42.1 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $80.7 billion in Q3 2023 and troughed at -$80.8 billion in Q2 2023.
  • A 5-year average of -$16.7 million and a median of -$15.0 million in 2025 frame the typical range for Net Cash Flow.
  • The widest YoY moves for Net Cash Flow: up 101594.25% in 2023, down 304144.48% in 2023.
  • Over 5 years, Net Cash Flow stood at $30.6 million in 2022, then tumbled by 262.38% to -$49.7 million in 2023, then soared by 117.34% to $8.6 million in 2024, then sank by 588.95% to -$42.1 million in 2025, then jumped by 86.87% to -$5.5 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$5.5 million, -$42.1 million, and -$19.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 18.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.73 Mn
Mar 31, 2026 -5.53 Mn
Dec 31, 2025 -39.58 Mn
Sep 30, 2025 -19.06 Mn
Jun 30, 2025 13.09 Mn
Mar 31, 2025 -15.02 Mn
Dec 31, 2024 10.27 Mn
Sep 30, 2024 29.05 Mn
Jun 30, 2024 -48.55 Mn
Mar 31, 2024 55.35 Mn
Dec 31, 2023 -48.38 Mn
Sep 30, 2023 87.94 Bn
Jun 30, 2023 -88.06 Bn
Mar 31, 2023 -33.56 Mn
Dec 31, 2022 30.77 Mn
Sep 30, 2022 -79.54 Mn
Jun 30, 2022 26.25 Mn
Mar 31, 2022 -39.28 Mn
Dec 31, 2021 111.05 Mn
Sep 30, 2021 -96.18 Mn